What the FDA Does and Doesn't Check

Most people assume that if a supplement is on the shelf, someone official checked that it works and is safe — the way they did for prescription drugs. For US dietary supplements, that assumption is mostly wrong, and the gap between what people think the FDA checks and what it actually checks is exactly where a lot of confusion lives.

Short Answer: In the US, the FDA regulates dietary supplements far more lightly than drugs: supplements don't require pre-market approval for safety or effectiveness, manufacturers are largely responsible for their own claims and quality, and the FDA mostly acts after problems arise. Understanding this gap — and what the standard disclaimer means — is essential supplement literacy.

Why This Matters

This is the single biggest supplement misconception. Under US law, dietary supplements are regulated as a category distinct from drugs: they do not require FDA pre-market approval for safety or effectiveness before being sold. [1]

Drugs must demonstrate safety and efficacy before approval. Supplements largely don't — the responsibility for safety and truthful labeling sits mainly with the manufacturer, with the FDA positioned to act mostly after a product is on the market.

Science Explanation

This is why supplements carry the familiar line that statements "have not been evaluated by the FDA" and that the product isn't intended to diagnose, treat, cure, or prevent disease. That disclaimer isn't boilerplate — it's a direct signal of the regulatory category, and of exactly what hasn't been vetted. [2]

What Research Shows

The framework isn't absent — the FDA sets manufacturing standards, can act against unsafe products or illegal disease claims, and oversees labeling rules. But this is largely post-market enforcement, not the pre-market gatekeeping people assume. The protections exist; they operate later in the process. [1]

Practically: don't read shelf presence as proof of efficacy or independent verification, weight third-party quality testing accordingly, and treat structure-function claims as permitted marketing language rather than vetted fact. This is the regulatory backdrop to the whole evidence pillar — and general education, not legal or medical advice. [1] Updated 2021 reporting standards for systematic reviews emphasise transparency in literature search methods, inclusion criteria, and risk-of-bias assessment as the key determinants of a review's reliability — providing a structured framework for evaluating any published evidence synthesis. [3]